HIV Drug Approvals Lift Hopes Amid Missed UN Targets
The recent approvals of long-acting HIV injections promise to lighten the load of HIV sufferers…
The recent approvals of long-acting HIV injections promise to lighten the load of HIV sufferers…
A monthly two-drug injection developed by the GSK spinoff ViiV Healthcare has been approved for…
The UK company ViiV Healthcare will begin a phase IIa trial of an antibody licensed…
An experimental HIV therapy being developed by GSK spinoff ViiV Healthcare in partnership with Janssen…
A first-in-class HIV treatment developed by the UK company ViiV Healthcare has suppressed the virus…
The two-drug pill Dovato, developed by the UK company ViiV Healthcare, has been approved as…
Update (04/04/2019): ViiV Healthcare's two-drug HIV treatment, Juluca, has successfully suppressed the HIV virus for…
Two phase III trials conducted by ViiV Healthcare have concluded that a monthly injection of…
A monthly antiviral injection may be as good as daily HIV drugs for suppressing infections,…
ViiV Healthcare reports promising data from two HIV treatments with two drugs instead of the…
ViiV Healthcare has just started a clinical trial to test if its two-drug regimen for…
This infographic gathers 10 of the best HIV treatments in Europe's pipeline that will help…